spacer
home > ebr > summer 2003 > trends in laboratory robotics in the biopharmaceutical industry
PUBLICATIONS
European Biopharmaceutical Review

Trends in Laboratory Robotics in the Biopharmaceutical Industry

This article does not seek to describe the history of laboratory robotics in the pharmaceutical and biotech industry, but rather outline current market trends and analyse the reasons behind these trends. However, a short summary of the evolution of laboratory robotics must be provided in order to fully understand the foundations of well automated functions upon which lab automation is building its future.

The development of laboratory robotics has been, and still is, primarily driven by the needs of pharmaceutical companies for two fundamental reasons:


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Christophe Fraudeau, Marketing Manager at Jouan Robotics

Christophe Fraudeau holds a Masters in Sciences/Engineering in Biochemistry from Institut National Agronomique in Paris and an MBA from Ecole Supйrieure de Commerce de Paris. After two years as Laboratory Manager in a private contract analysis laboratory, he spent six years with Gilson as International Product Manager in charge of the automated sample preparation product line. In 2001 he joined the Jouan Group (Nantes, France) as Marketing Manager for the newly created Robotics Division.

spacer
Christophe Fraudeau
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Data custodianship of connected devices, environmental impact and adherence technologies highlighted at Pharmapack Europe 2020

Paris, 19th February 2020: Improving adherence to medication via smarter, patient-centric pharmaceutical packaging and extracting further value from existing medicines and delivery devices are two of the latest key strategies aimed at reducing waste and protecting the bottom line, according to experts at the recent Pharmapack Europe (#pharmapackeu). The event is widely seen as an excellent yardstick of the industry’s prospects for the year ahead. Encouragingly, the event played host a record 411 exhibiting companies, 5366 attendees and 325 delegates.
More info >>

White Papers

PROTEIN:PROTEIN INTERACTION ANALYSIS

IBA GmbH

Groth et al., 2007 and Jasencakova et al., 2010 Protein:protein-interactions (PPI) govern almost all important processes in living organisms. Thus, their rapid and accurate determination and investigation is a major challenge in life sciences. The extremely efficient and fast One-STrEP (Twin-Strep) system is suitable for the isolation of functional protein complexes and subsequent mass spectrometry analysis leads to the identification of protein complex components (Junttila et al., 2005) as it is shown in the following studies.
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement